Profesionales de la Salud.
De mi consideración:
En relación a las vacunas tengo muchas dudas.
Estas son algunas de las preguntas me gustaría tengan ustedes la amabilidad de responder:
Cuáles son los estudios realizados para asegurar que las vacunas son seguras y eficaces. En Argentina o en otro país. Por favor, bríndenme la fuente a la que pueda consultar. Así como también, los datos de los laboratorios argentinos independientes que analizan las vacunas que nos inyectan.
Según prospectos del laboratorio productor de las vacunas: Las vacunas no se han probado para determinar su efecto carcinogénico, efecto mutagénico y cómo afecta la fertilidad. Punto 13.1 de cada prospecto de vacunas.
Por qué no se entregan los prospectos de las vacunas a las personas antes de vacunarlas? Han leído los prospectos? Saben que el aluminio es un potente neurotóxico?
Según el CDC de los Estados Unidos (Centro para el Control y la Prevención de Enfermedades), las vacunas contienen: Cultivo de células embrionarias de pollo, fibroblastos de pulmón diploide humano, suero bovino fetal, glutamato, albumina humana recombinante, neomicina (antibiótico), sorbitol, gelatina hidrolizada, fosfato de sodio, cloruro de sodio, formaldehído, hidróxido de aluminio, polisorbato, fosfato de aluminio, formaldehído, glutaraldehído, albúmina de suero bovino, sulfato de amonio, medio de casamino Mueller-Miller modificado de corazón de vaca, ….
Saben cuáles son los efectos secundarios que pueden causar?
Estas son algunas de las reacciones adversas que pueden producir las vacunas, según los prospectos de los laboratorios que producen las vacunas:
Infecciones del tracto respiratorio, otitis media, linfadenopatía, reacciones alérgicas, anorexia, ansiedad, llanto persistente, insomnio, calambres por fiebre, conjuntivitis, bronquitis, tos, dolor de cabeza agudo y prolongado, glándulas parótidas agrandadas, diarrea, vómitos, erupción cutánea, fiebre ≥38 °, convulsiones, meningitis, síndrome tipo sarampión, Síndrome tipo paperas, Trombocitopenia, púrpura trombocitopénica, Reacciones anafilácticas, Encefalitis, Cerebelitis, trastornos de marcha, ataxia (dificultad para coordinar los movimientos), síndrome de Guillain-Barré, Mielitis transversa, neuritis periférica, Vasculitis (inflamación vascular), Eritema multiforme, Artralgia, epilepsia, artritis (dolor muscular y articular), autismo…
Por qué los profesionales de la salud no informan, apropiadamente a los padres, los efectos adversos que pueden ocasionar las vacunas?
Por qué no advierten que los eventos adversos luego de las vacunas deben ser informados en el ANMAT?
Lo cual está regulado por este organismo.
Por qué no se tienen en cuenta, previo a la vacunación, los antecedentes familiares de reacciones adversas a vacunas, alergias y predisposición genética, antecedentes de enfermedades autoinmune, afecciones neurológicas, convulsiones, casos de personas inmunodeprimidas, etc.?
Esto se advierte en los prospectos de las vacunas. Porque se vacuna masivamente siendo que todos somos seres diferentes? Ustedes tendrían en cuenta estas diferencias si se tratase de cualquier otro medicamento.
Desde cuándo, las enfermedades benignas de la infancia, comenzaron a tratarse como hechos terroríficos?
Cuál es el fundamento científico por el cual es correcto dar una vacuna contra la Hepatitis B a un recién nacido?
La Hepatitis B se contagia por relación sexual o por compartir agujas contaminadas. Actividades que un bebé no realiza.
Cuál es la razón por la que se decidió vacunar a embarazadas?
Las vacunas no se han probado para determinar su efecto carcinogénico, efecto mutagénico y cómo afecta la fertilidad. Punto 13.1 de cada prospecto de vacunas.
Además, contienen timerosal, un derivado del mercurio, el cual muchos cuestionan por su toxicidad. Lo cual, por lo menos, merece un estudio profundo para descartar efectos adversos.
Saben que en EEUU se han pagado más de U$S4.000.000.000 (CUATRO MIL MILLONES) en indemnizaciones por efectos adversos de vacunas (a enero 2019)?
Si las vacunas son tan seguras, ¿por qué́ los fabricantes de vacunas disfrutan de inmunidad frente a reclamos de daños y perjuicios?
Saben que Suecia ha prohibido las vacunas obligatorias, citando “serias preocupaciones de salud” y el hecho de que violan los derechos constitucionales de los ciudadanos a elegir su propia atención médica?
La Federación Nacional de Salud de Suecia en su Carta al Parlamento de Estocolmo sostuvo que “viola el Convenio Europeo de Derechos Humanos, es contrario al Código de Núremberg y la Declaración de Helsinki. La vacunación tiene base científica insatisfactoria. Toda vacunación debe ser considerada un experimento masivo”.
“Las iniciativas políticas para forzar a las personas a vacunarse contra su voluntad es una acción que podría clasificarse legítimamente como un intento de asesinato, así́ como también intentar causar lesiones corporales. Es indiscutible que la vacunación con certeza lleva efectos secundarios graves, enfermedad e incluso muerte.”
Por qué seguimos el calendario de vacunación de EEUU?
En este país más del 50% de los niños tiene enfermedades crónicas y, además, tiene el índice de muerte en menores de 1 año más alto de entre los países industrializados.
Cuáles son los estudios científicos realizados, luego de la aplicación de las vacunas, que confirmen su seguridad?
Conocen al Dr. William Thompson?
William Thompson, científico jefe del CDC de EEUU. En 2014 confesó que se ocultaron datos en un estudio realizado en 2004. Estudio que se hizo para probar que la vacuna MMR no tiene vinculación con el autismo regresivo. El Dr. Thompson admitió que, en la publicación, no se consideraron los elementos que confirmaban la vinculación de la MMR con el autismo y que cuanto más pequeños los niños, mayor era la incidencia. Envió 10.000 hojas de pruebas de esto al congresista Bill Posey quien pidió, en julio 2015, que se lo citara a declarar en el Congreso. Hasta el momento, no lo citaron.
Thompson lo confesó también, al Dr. Hooker, con un hijo autista, ya que quería aliviar su remordimiento y hacer público este fraude. Todo esto se explica en la documental VAXXED: DEL ENCUBRIMIENTO A LA CATÁSTROFE.
Conocen los argumentos de los profesionales de salud agrupados en “Nurses against all vaccines”, Enfermeras en contra de todas las vacunas, https://www.facebook.com/Nursesagainstallvaccines/ y de “Physician for informed consent”, Médicos por el Consentimiento Informado, https://physiciansforinformedconsent.org/. Cuál es su opinión al respecto?
Respetuosamente, espero que ustedes coincidan en que es necesario analizar estos temas profundamente para el interés de nuestro país.
La vacunación es una intervención médica con altos riesgos y como tal se nos debe informar acerca de sus consecuencias y darnos la libertad de elegir si queremos hacernos cargo de las mismas.
“PRIMERO NO DAÑAR”
Desde ya muchas gracias,
Anexo A: Informes de 3 Científicos enviados al Departamento de Salud de los Estados Unidos y al CDC. En ellos advierten sobre la utilización de aluminio en las vacunas. Este componente es NEUROTÓXICO. Y ellos expresan que la leyenda en la página del CDC que dice: “Las vacunas no causan autismo” carece de sustento científico. Christopher Shaw de Canadá, Romain K. Gherardi de Francia y Christopher Exley PhD de Reino Unido.
Anexo B: 50 Estudios Científicos adjuntados al Parlamento sueco por la Federación de Médicos de ese país.
Anexo C: Bibliografía.
Anexo D: Listado de los ingredientes contenidos en cada vacuna. Centro de Control de Enfermedades de EEUU. (CDC).
June 15, 2017
United States Department of Health & Human Services
National Institutes of Health
Food & Drug Administration
Centers for Disease Control & Prevention
200 Independence Avenue, S.W.
Washington, D.C. 20201
Re: Aluminum Adjuvants
I am an expert in the field of aluminum adjuvants toxicityin humans and animal models. I have been working in this fieldsince the initial description of the Al vaccine-induced
macrophagic myofasciitis in 1998. Since that time I have written40 peer-reviewed scientific publications and one book on thissubject.
I strongly support the contention that aluminumadjuvants in vaccines may have a role in the etiology of autismspectrum disorder (ASD). My view is founded on a significant
and burgeoning body of peer-reviewed scientific evidencewhich makes the link between ASD and exposure to aluminumthrough vaccinations and other sources. Examples of this
literature from my own group are detailed below and I urge theHHS to take them into consideration in forming any futureopinion on the safety of aluminum adjuvants in vaccines.
The Center for Disease Control’s claim on its websitethat “Vaccines Do Not Cause Autism” is unsupported withrespect to aluminum adjuvants and this claim stifles the
important research to determine the safety of aluminum adjuvants used in vaccines. As an expert in the field ofaluminum adjuvants and aluminum toxicity I solemnly declare
that more research on the role of aluminum adjuvant invaccines and neurological disorders, including ASD, is essentialand urgently required.
Yours very sincerely
Romain K. Gherardi
Professor, Neuromuscular Pathology Expert Centre
University Paris-Est, INSERM U955-E10,
Henri Mondor hospital, Créteil France
Contact at the hospital
Tel 00 (33) 1 49812746
Selection of significant publications from our group in the field
Gherardi R. Toxic Story: deux ou trois vérités embarrassantes sur les adjuvants des vaccins.
Actes Sud (publisher), Paris, 2016, 250 pages
Crépeaux G, Eidi H, David MO, Baba-Amer Y, Tzavara E, Giros B, Authier FJ, Exley C, Shaw CA,
Cadusseau J, Gherardi RK. Non-linear dose-response of aluminium hydroxide adjuvant particles:
Selective low dose neurotoxicity. Toxicology. 2017 Jan 15;375:48-57.
Masson JD, Crépeaux G, Authier FJ, Exley C, Gherardi RK. [Critical analysis of
reference studies on aluminium-based adjuvants toxicokinetics]. Ann Pharm Fr.
2017 May 30. pii: S0003-4509(17)30033-0.
Van Der Gucht A, Aoun Sebaiti M, Guedj E, Aouizerate J, Yara S, Gherardi RK,
Evangelista E, Chalaye J, Cottereau AS, Verger A, Bachoud-Levi AC, Abulizi M,
Itti E, Authier FJ. Brain (18)F-FDG PET Metabolic Abnormalities in Patients with
Long-Lasting Macrophagic Myofascitis. J Nucl Med. 2017 Mar;58(3):492-498.
Crépeaux G, Eidi H, David MO, Tzavara E, Giros B, Exley C, Curmi PA, Shaw CA,
Gherardi RK, Cadusseau J. Highly delayed systemic translocation of aluminum-based
adjuvant in CD1 mice following intramuscular injections. J Inorg Biochem. 2015 Nov;152:199-
Eidi H, David MO, Crépeaux G, Henry L, Joshi V, Berger MH, Sennour M,
Cadusseau J, Gherardi RK, Curmi PA. Fluorescent nanodiamonds as a relevant tag
for the assessment of alum adjuvant particle biodisposition. BMC Med. 2015 Jun
Van Der Gucht A, Aoun Sebaiti M, Itti E, Aouizerate J, Evangelista E, Chalaye
J, Gherardi RK, Ragunathan-Thangarajah N, Bachoud-Levi AC, Authier FJ.
Neuropsychological Correlates of Brain Perfusion SPECT in Patients with
Macrophagic Myofasciitis. PLoS One. 2015 Jun 1;10(6):e0128353.
Khan Z, Combadière C, Authier FJ, Itier V, Lux F, Exley C, Mahrouf-Yorgov M,
Decrouy X, Moretto P, Tillement O, Gherardi RK, Cadusseau J. Slow CCL2-dependent
translocation of biopersistent particles from muscle to brain. BMC Med. 2013 Apr
Couette M, Boisse MF, Maison P, Brugieres P, Cesaro P, Chevalier X, Gherardi
RK, Bachoud-Levi AC, Authier FJ. Long-term persistence of vaccine-derived
aluminum hydroxide is associated with chronic cognitive dysfunction. J Inorg
Biochem. 2009 Nov;103(11):1571-8.
Authier FJ, Sauvat S, Christov C, Chariot P, Raisbeck G, Poron MF, Yiou F,
Gherardi R. AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is
influenced by the genetic background. Neuromuscul Disord. 2006 May;16(5):347-52.
Authier FJ, Sauvat S, Champey J, Drogou I, Coquet M, Gherardi RK. Chronic fatigue syndrome in
patients with macrophagic myofasciitis. Arthritis Rheum. 2003 Feb;48(2):569-70.
Gherardi RK. [Lessons from macrophagic myofasciitis: towards definition of a
vaccine adjuvant-related syndrome]. Rev Neurol (Paris). 2003 Feb;159(2):162-4.
Authier FJ, Cherin P, Creange A, Bonnotte B, Ferrer X, Abdelmoumni A, Ranoux
D, Pelletier J, Figarella-Branger D, Granel B, Maisonobe T, Coquet M, Degos JD,
Gherardi RK. Central nervous system disease in patients with macrophagic
myofasciitis. Brain. 2001 May;124(Pt 5):974-83.
Gherardi RK, Coquet M, Cherin P, Belec L, Moretto P, Dreyfus PA, Pellissier
JF, Chariot P, Authier FJ. Macrophagic myofasciitis lesions assess long-term
persistence of vaccine-derived aluminium hydroxide in muscle. Brain. 2001
Gherardi RK, Coquet M, Chérin P, Authier FJ, Laforêt P, Bélec L,
Figarella-Branger D, Mussini JM, Pellissier JF, Fardeau M. Macrophagic
myofasciitis: an emerging entit. Lancet. 1998 Aug 1;352(9125):347-52.
Tel: 01782 734080
Fax: 01782 712378
June 15, 2017
United States Department of Health & Human Services
National Institutes of Health
Food & Drug Administration
Centers for Disease Control & Prevention
200 Independence Avenue, S.W.
Washington, D.C. 20201
Re: Aluminum Adjuvants
I am an expert in the field of aluminum adjuvants and aluminum toxicity. I have been
working in this field for more than 30 years during which time I have written in excess of 150
peer-reviewed scientific publications on this subject.
I strongly support the contention that aluminum adjuvants in vaccines may have a role
in the etiology of autism spectrum disorder (ASD). My view is founded on a significant and
burgeoning body of peer-reviewed scientific evidence which makes the link between ASD
and exposure to aluminum through vaccinations and other sources. Examples of this literature
from my own group are detailed below and I urge the HHS to take them into consideration in
forming any future opinion on the safety of aluminum adjuvants in vaccines.
The Center for Disease Control’s claim on its website that “Vaccines Do Not Cause
Autism” is unsupported with respect to aluminum adjuvants and this claim stifles the
important research to determine the safety of aluminum adjuvants used in vaccines. As an
expert in the field of aluminum adjuvants and aluminum toxicity I solemnly declare that more
research on the role of aluminum adjuvant in vaccines and neurological disorders, including
ASD, is essential and urgently required.
Christopher Exley PhD
Professor in Bioinorganic Chemistry
Honorary Professor, University of the Highlands and Islands
List of Recent, Relevant and Significant Publications From Our Group
Exley C, Siesjö P & Eriksson H (2010) The immunobiology of aluminium adjuvants: how do they really work?
Trends in Immunology 31, 103-109.
Exley C and House E (2011) Aluminium in the human brain. Monatshefte für Chemie - Chemical Monthly 142,
House E, Esiri M, Forster G, Ince PG and Exley C (2012) Aluminium, iron and copper in human brain tissues
donated to the medical research council’s cognitive function and ageing study. Metallomics 4, 56-65.
Exley C (2011) Aluminium-based adjuvants should not be used as placebos in clinical trials. Vaccine 29, 9289.
Exley C (2012) When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination
programmes. Vaccine 30, 2042.
Exley C (2012) The coordination chemistry of aluminium in neurodegenerative disease. Coordination Chemistry
Reviews 256, 2142-2146.
Exley C, House E, Polwart A and Esiri MM (2012) Brain burdens of aluminium, iron and copper and their
relationships with amyloid beta pathology in 60 human brains. Journal of Alzheimer’s Disease 31, 725-730.
Davenward S, Bentham P, Wright J, Crome P, Job, D, Polwart A and Exley C (2013) Silicon-rich mineral water
as a non-invasive test of the ‘aluminium hypothesis’ in Alzheimer’s disease. Journal of Alzheimer’s Disease 33,
Khan Z, Combadière C, Authier FJ, Itier V, Lux F, Exley C, Mahrouf-Yorgov M, Decrouy X, Moretto P,
Tillement O, Gherardi RK, and Cadusseau J (2013) Slow CCL2-dependent translocation of biopersistent
particles from muscle to brain. BMC Medicine 11:99.
Exley C (2013) Human exposure to aluminium. Environmental Science:Processes and Impacts 15, 1807-1816.
Ohlsson L, Exley C, Darabi A, Sandén E, Siesjö P and Eriksson H (2013) Aluminium based adjuvants and their
effects on mitochondria and lysosomes of phagocytosing cells. Journal of Inorganic Biochemistry 128, 229-236.
Exley C (2014) Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy. Allergy,
Asthma and Clinical Immunology 10, 4.
Exley C and Vickers T (2014) Elevated brain aluminium and early onset Alzheimer’s disease in an individual
occupationally exposed to aluminium: a case report. Journal of Medical Case Reports 8,41.
Exley C (2014) What is the risk of aluminium as a neurotoxin? Expert Review of Neurotherapeutics 14, 589-
Mold M, Eriksson H, Siesjö P, Darabi A, Shardlow E and Exley C (2014) Unequivocal identification of
intracellular aluminium adjuvant in a monocytic THP-1 cell line. Scientific Reports 4, 6287.
Exley C (2014) Why industry propaganda and political interference cannot disguise the inevitable role played by
human exposure to aluminium in neurodegenerative diseases, including Alzheimer’s disease. Frontiers in
Neurology 5:212. doi: 10.3389/fneur.2014.00212.
Crépeaux G, Eidi H, David M-O, Tzavara E, Giros B, Exley C, Curmi PA, Shaw CA, Gherardi RK and
Cadusseau J (2015) Highly delayed systemic translocation of aluminium-based adjuvant in CD1 mice following
intramuscular injections. Journal of Inorganic Biochemistry 152, 199-205.
Exley C (2016) The toxicity of aluminium in humans. Morphologie 100, 51-55.
Mirza A, King A, Troakes C and Exley C (2016) The identification of aluminium in human brain tissue using
lumogallion and fluorescence microscopy. Journal of Alzheimer’s Disease 54, 1333-1338.
Mold M, Shardlow E and Exley C (2016) Insight into the cellular fate and toxicity of aluminium adjuvants used
in clinically-approved human vaccinations. Scientific Reports 6:31578.
Mirza A, King A, Troakes C and Exley C (2017) Aluminium in brain tissue in familial Alzheimer’s disease.
Journal of Trace Elements in Medicine and Biology 40, 30-36.
Shardlow E, Mold M and Exley C (2017) From stock bottle to vaccine: Elucidating the particle size distributions
of aluminium adjuvants using dynamic light scattering. Frontiers in Chemistry 4, 48.
Exley C (2017) Aluminium should now be considered a primary aetiological factor in Alzheimer’s disease.
Journal of Alzheimer’s Disease Reports 1, 23-25.
June 24, 2017
United States Department of Health & Human Services
National Institutes of Health
Food & Drug Administration
Centers for Disease Control & Prevention
200 Independence Avenue, S .W.
Re: Aluminum Adjuvants
I am writing to you in regard to aluminum adjuvants in vaccines. This subject is one my laboratory works on intensively and therefore one where I feel that I have some expertise.
In particular, we have studied the impact of aluminum adjuvants in animal models of neurological disease, including autism spectrum disorder (ASD). Our relevant studies on the general topic of aluminum neurotoxicity in general and specifically in regard to adjuvants are cited below.
These studies and the broader existing literature regarding aluminum toxicity, lead almost invariably to the conclusion that aluminum in any chemical form is always neurotoxic when administered to humans. Further, I am convinced that aluminum adjuvants in vaccines may contribute to neurological disorders across the lifespan. In adults, such adjuvant may induce macrophagic myofasciitis, a disease with neuropathological aspects. In children, there is growing evidence that aluminum adjuvants may disrupt developmental processes in the central nervous system and therefore contribute to ASD in susceptible children.
Despite the foregoing, the safety of aluminum adjuvants in vaccines has not been properly studied in humans even though, pursuant to the recommended vaccine schedule published by the Center of Disease Control (CDC), a baby may be injected with up to 3,67 5 micrograms of aluminum adjuvant by six months of age.
In regard to the above, it is my belief that the CDC's claim on its website that "Vaccines Do Not Cause Autism" is wholly unsupported. Given this, I remain convinced that much more research on the role of aluminum adjuvant in vaccines and neurological disorders, including ASD, is warranted and should be a research priority for the NIH and other funding bodies.
Christopher A. Shaw, Ph.D
Dept. of Ophthalmology and Visual Sciences
University of British Columbia
828 W. l0'Ave.
Vancouver, British Columbia
Tel: 604-875-411 I (ext. 68373)
Email : firstname.lastname@example.org
Relevant Publications(Shaw Laboratory)
l. Crepeaux G , Eidi H, David MO, Baba-AmeYr , Tzavara E,g iros B , authierF J,Exley C, ShawC A, CadusseaJu, GherardRi K. Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective dose neurotoxicity. Toxicology 375:48-5, 7 20l6).
2. crepeaux G , Eidi H, David M-o, Tzavara E , Giros B , Exley c, curmi PA, Shaw c A, Gherard Ri K, Cadussea Ju. Highly delayed systemic translocation of aluminium-based adjuvant in CDI mice following intramuscular injections. J. Inorg. Biochem.1 5 2:199-2 05.( 201 5 ).
3. Shaw C A, Li D, Tomljenovic L. Are there negative CNS impacts of aluminum adjuvants in vaccines and immunotherapy? Immunotherapy. 6 (I 0): I 055-I 07 l. (2014 ).
4. Shaw C A, Seneff S , Kette S D, Tomljenovic L , Oller Jr JW, Davidson R M. Aluminum-induced entropy in biological systems :Implications for neurological disease. J Toxicology Volume 2014, Article lD 491316. (2014).
5. Shaw C A, Kette S D, DavidsonR M, Sniffs. Aluminum's role in CNS-immune system interactions leading to neurological disorders. Immunome Res.9:1.
6. Shaw C A, Marler TE. Aluminum and the human diet revisited. In: Communicative Integrative Biology; Landes Bioscience. 6.:e26369 (.2 0l3).
7. Shaw C A, Tomljenovic L. Aluminum in the central nervous system (CNS): toxicity in humans and animals, Vaccine adjuvants and autoimmunity Immunol Res (2013).
8. Shaw C A, Li Y, Tomljenovic L. Administration of aluminum to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes JInorg Chem.( 2013).
9, Tomljenovic L , Shaw C A. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations Lu pus.2 l :223-2 30.( 2012).
10. Tomljenovic L andS haw C A. Editorial SpeciaI lssue The Biochemistry/Toxicity of Aluminum, Current Inorganic Chemistry 2. (l): 1- 2. (2012).
11. Tomljenovic L and Shaw C A. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J InorgB iochem1. 05(11):1489-(9290.1 l).
12. Tomljenovic L and Shaw C A. Aluminum vaccine adjuvants Are they safe? Current Medicinal Chemistry. 18:263-02 637. (201l).
13. Shaw C A and Petrik M S. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration J Inorganic Biochem.103( l 1): 1555-62(.2 009).
14. Petrik M S, Wong M C, Tabata RC,Garry R F, and Shaw C A. Aluminum adjuvant linked to Gulf War illness Induces motor neuron death in mice. J Neuromolecular Medicine. 9: 83-100. (2007).
1. CIENTÍFICOS DE YALE ENCUENTRAN UNA FUERTE ASOCIACIÓN ENTRE LAS VACUNAS Y LA ANOREXIA, EL TRASTORNO OBSESIVO COMPULSIVO (TOC) Y LA ANSIEDAD. YALE SCIENTISTS FIND STRONG ASSOCIATION BETWEEN VACCINATIONS AND ANOREXIA, OCD, AND ANXIETY DISORDER
Temporal Association of Certain Neuropsychiatric Disorders Following Vaccination of Children and Adolescents: A Pilot Case-Control Study Frontiers in Psychiatry, January 2017, Douglas L. Leslie, Robert A. Kobre, Brian J. Richmand
Summary: "Subjects with newly diagnosed anorexia nervosa were more likely than controls to have had any vaccination in the previous 3 months [hazard ratio (HR) 1.80, 95% confidence interval 1.21-2.68]. Influenza vaccinations during the prior 3, 6, and 12 months were also associated with incident diagnoses of AN, OCD, and an anxiety disorder. Several other associations were also significant with HRs greater than 1.40 (hepatitis A with OCD and AN; hepatitis B with AN; and meningitis with AN and chronic tic disorder). This pilot epidemiologic analysis implies that the onset of some neuropsychiatric disorders may be temporally related to prior vaccinations in a subset of individuals."
2. CIENTÍFICOS ITALIANOS ENCUENTRAN CONTAMINANTES INESPERADOS EN TODAS LAS VACUNAS PEDIÁTRICAS, INCLUYENDO PLOMO, ACERO INOXIDABLE, TUNGSTENO, HIERRO Y CROMO. ITALIAN SCIENTISTS FIND UNEXPECTED CONTAMINANTS IN ALL PEDIATRIC VACCINES, INCLUDING LEAD, STAINLESS STEEL, TUNGSTEN, IRON, AND CHROMIUM
New Quality-Control Investigations on Vaccines: Micro- and Nanocontamination International Journal of Vaccines and Vaccination, January 2017, Dr. Antonietta M. Gatti, Stefano Montanari
Summary: Scientists found contaminants in all vaccines that are not listed on the label of the vaccines. "The analyses carried out show that in all samples checked vaccines contain non biocompatible and bio-persistent foreign bodies which are not declared by the Producers, against which the body reacts in any case. This new investigation represents a new quality control that can be adopted to assess the safety of a vaccine. Our hypothesis is that this contamination is unintentional, since it is probably due to polluted components or procedures of industrial processes (e.g. filtrations) used to produce vaccines, not investigated and not detected by the Producers. If our hypothesis is actually the case, a close inspection of the working places and the full knowledge of the whole procedure of vaccine preparation would probably allow to eliminate the problem."
3. CIENTÍFICOS ISRAELÍES E ITALIANOS ADVIERTEN QUE LOS ADJUVANTES DE LAS VACUNAS (ALUMINIO) CAUSAN UNA AMPLIA GAMA DE ENFERMEDADES AUTOINMUNES, INCLUYENDO EL SÍNDROME DE SJOGREN. ISRAELI AND ITALIAN SCIENTISTS WARN THAT VACCINE ADJUVANTS (ALUMINUM) ARE CAUSING A WIDE-RANGE OF AUTOIMMUNE CONDITIONS, INCLUDING SJOGREN'S SYNDROME
Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Sjogren's Syndrome IMAJ VOL 18, March-April 2016, Serena Colafrancesco, Carlo Perricone, Yehuda Shoenfeld
Summary: "Several case reports have suggested that both vaccines and silicone may trigger the development of SS [Sjo?gren's syndrome, a chronic systemic autoimmune inflammatory condition involving the exocrine glands]. Aluminum is one of the principal adjuvants used in vaccine formulation and may be responsible for the development of ASIA syndrome. It seems that its ability to behave as an adjuvant might be related to evidence that aluminum salts seem to both induce the activation of dendritic cells and complement components and increase the level of chemokine secretion at the injection site... other vaccines including Bacillus Calmette Gue?rin (BCG), hepatitis A and/or B and human papillomavirus, should be avoided or considered only in selected patients... There is considerable evidence raising the possibility of vaccine-triggered autoimmunity"
4. NIÑOS VACUNADOS CON MÚLTIPLES VACUNAS DE UNA VEZ, TIENEN MUCHO MÁS ALTA TASA DE HOSPITALIZACIÓN Y DE MUERTE QUE NIÑOS QUE RECIBIERON MENOS VACUNAS SIMULTÁNEAS. INFANTS VACCINATED WITH MULTIPLE VACCINES AT ONCE HAVE MUCH HIGHER HOSPITALIZATIONS AND DEATH RATES THAN INFANTS WHO RECEIVE FEWER SIMULTANEOUS VACCINES
Combining Childhood Vaccines at One Visit Is Not Safe Journal of American Physicians and Surgeons, Summer 2016, Neil Z. Miller
Summary: "Our study showed that infants who receive several vaccines concurrently, as recommended by CDC, are significantly more likely to be hospitalized or die when compared with infants who receive fewer vaccines simultaneously. It also showed that reported adverse effects were more likely to lead to hospitalization or death in younger infants. The safety of CDC's childhood vaccination schedule was never affirmed in clinical studies. Vaccines are administered to millions of infants every year, yet health authorities have no scientific data from synergistic toxicity studies on all combinations of vaccines that infants are likely to receive. National vaccination campaigns must be supported by scientific evidence."
5. CIENTÍFICOS ISRAELÍES, CANADIENSES Y COLOMBIANOS MUESTRAN QUE GARDASIL CAUSA INFLAMACIÓN EN EL CEREBRO Y AUTOINMUNIDAD EN RATAS. ISRAELI, CANADIAN, AND COLOMBIAN SCIENTISTS SHOW THAT GARDASIL VACCINE TRIGGERS BRAIN INFLAMMATION AND AUTOIMMUNITY IN MICE
Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil Immunol Res, July 2016, Rotem Inbar, Ronen Weiss, Lucija Tomljenovic, Maria-Teresa Arango, Yael Deri, Christopher A, Shaw, Joab Chapman, Miri Blank, Yehuda Shoenfeld
Summary: "Vaccine adjuvants and vaccines may induce autoimmune and inflammatory manifestations in susceptible individuals. To date most human vaccine trials utilize aluminum (Al) adjuvants as placebos despite much evidence showing that Al in vaccine-relevant exposures can be toxic to humans and animals...It appears that Gardasil via its Al adjuvant and HPV antigens has the ability to trigger neuroinflammation and autoimmune reactions, further leading to behavioral changes...In light of these findings, this study highlights the necessity of proceeding with caution with respect to further mass-immunization practices with a vaccine of yet unproven long-term clinical benefit in cervical cancer prevention"
6. EL ALUMINIO EN LAS VACUNAS ES ALTAMENTE NEUROTÓXICO Y LOS NIVELES DE EXPOSICIÓN EN NIÑOS SE HAN INCREMENTADO DRAMÁTICAMENTE. ALUMINUM IN VACCINES IS HIGHLY NEUROTOXIC AND EXPOSURE LEVELS GIVEN TO INFANTS HAVE DRAMATICALLY INCREASED
Aluminum in Childhood Vaccines Is Unsafe Journal of American Physicians and Surgeons, Winter 2016, Neil Z. Miller
Summary: "Infants and young children throughout the world receive high quantities of aluminum from multiple inoculations. Incremental changes to the vaccination schedule during the past several years significantly increased the quantity of aluminum in childhood shots. Numerous studies provide compelling evidence that injected aluminum can be detrimental to health. Aluminum is capable of remaining in cells long after vaccination and may cause neurologic and autoimmune disorders. During early development, the child's brain is more susceptible to toxins and the kidneys are less able to eliminate them. Thus, children have a greater risk than adults of adverse reactions to aluminum in vaccines. Millions of children every year are injected with vaccines containing mercury and aluminum despite well-established experimental evidence of the potential for additive or synergistic toxicity when an organism is exposed to two or more toxic metals."
7. LAS VÍCTIMAS DE ALZHEIMER TIENEN ELEVADOS NIVELES DE ALUMINIO EN EL CEREBRO, UNA NEUROTOXINA POTENTE. ALZHEIMER'S VICTIMS HAVE VERY HIGH BRAIN ALUMINUM LEVELS, A POTENT NEUROTOXIN
Aluminium in brain tissue in familial Alzheimer's disease Journal of Trace Elements in Medicine and Biology, November 2016, Ambreen Mirza, Andrew King, Claire Troakes, Christopher Exley
Summary: "Aluminium has been shown to be present in brain tissue in sporadic Alzheimer's disease. We have made the first ever measurements of aluminium in brain tissue from 12 donors diagnosed with familial Alzheimer's disease. The concentrations of aluminium were extremely high, for example, there were values in excess of 10??g/g tissue dry wt. in 5 of the 12 individuals. Overall, the concentrations were higher than all previous measurements of brain aluminium except cases of known aluminium-induced encephalopathy. We have supported our quantitative analyses using a novel method of aluminium-selective fluorescence microscopy to visualise aluminium in all lobes of every brain investigated. The unique quantitative data and the stunning images of aluminium in familial Alzheimer's disease brain tissue raise the spectre of aluminium's role in this devastating disease."
8. LAS VACUNAS IMPLICADAS EN LAS EPIDEMIAS DE LAS ALERGIAS ALIMENTARIAS. VACCINES IMPLICATED IN EPIDEMIC OF FOOD ALLERGIES
Evidence that Food Proteins in Vaccines Cause the Development of Food Allergies and Its Implications for Vaccine Policy Journal of Developing Drugs, 2015, Vinu Arumugham
Summary: "Numerous studies have demonstrated that food proteins contained in vaccines/injections induce food allergy. The IOM's authoritative report has concluded the same. Allergen quantities in vaccines are unregulated. Today kids are more atopic. C-section births bias the newborn's immune system towards IgE synthesis due to sub-optimal gut microbiome . C-section birth rates have gone up 50% in the last few decades. The vaccine schedule has increased the number of vaccine shots to 30-40 and up to five vaccines are simultaneously administered to children. Vaccines also contain adjuvants such as aluminum compounds and pertussis toxin that bias towards IgE synthesis. Given these conditions, the predictable and observed outcome is a food allergy epidemic."
9. CIENTÍFICOS CHINOS ENCUENTRAN QUE LAS RATAS INYECTADAS CON THIMEROSAL (MERCURIO QUE SE ENCUENTRA EN LAS VACUNAS) TIENEN TRASTORNOS DE COMPORTAMIENTO SIMILARES AL AUTISMO. CHINESE SCIENTISTS FIND MICE INJECTED WITH THIMEROSAL (VACCINE MERCURY) HAVE BEHAVIORAL IMPAIRMENTS SIMILAR TO AUTISM
Transcriptomic Analyses of Neurotoxic Effects in Mouse Brain After Intermittent Neonatal Administration of Thimerosal Toxicological Sciences, March 2014, Xialong Li, Fengqin Qu, Wenjuan Xe, Fengli Wang, Hongmei Lui
Summary: "Thimerosal-treated mice exhibited neural development delay, social interaction deficiency, and inclination of depression. Apparent neuropathological changes were also observed in adult mice neonatally treated with thimerosal. High-throughput RNA sequencing of autistic-behaved mice brains revealed the alternation of a number of canonical path- ways involving neuronal development, neuronal synaptic function, and the dysregulation of endocrine system."
10. LOS DESÓRDENES DE DESARROLLO NEUROLÓGICO SON MUCHO MÁS COMUNES EN NIÑOS QUE RECIBIERON VACUNAS CONTENIENDO MERCURIO. NEURODEVELOPMENTAL DISORDERS ARE MUCH MORE COMMON IN CHILDREN WHO RECEIVED MERCURY-CONTAINING VACCINES
A Dose-Response Relationship between Organic Mercury Exposure from Thimerosal-Containing Vaccines and Neurodevelopmental Disorders Int. J. Environ. Res. Public Health, 2014, David A. Geier, Brian S. Hooker, Janet K. Kern, Paul G. King, Lisa K. Sykes and Mark R. Geier
Summary: "On a per microgram of organic-Hg basis, PDD (odds ratio (OR) = 1.054), specific developmental delay (OR = 1.035), tic disorder (OR = 1.034) and hyperkinetic syndrome of childhood (OR = 1.05) cases were significantly more likely than controls to receive increased organic-Hg exposure. This study provides new epidemiological evidence supporting a significant relationship between increasing organic-Hg exposure from TCVs and the subsequent risk of an ND diagnosis."
11. LA EPIDEMIA DE AUTISMO ES REAL Y POR LO TANTO DEBE SER EL PRODUCTO DE UN FACTOR AMBIENTAL. UC-BOULDER PROFESSOR: THE AUTISM EPIDEMIC IS REAL AND THEREFORE MUST BE THE PRODUCT OF AN ENVIRONMENTAL FACTOR
A comparison of temporal trends in United States autism prevalence to trends in suspected environmental factors Environmental Health, 2014, Cynthia D Nevison
Summary: "Diagnosed autism prevalence has risen dramatically in the U.S over the last several decades and continued to trend upward as of birth year 2005. The increase is mainly real and has occurred mostly since the late 1980s."
12. NIÑOS COMPLETAMENTE VACUNADOS REQUIEREN MUCHO MÁS CUIDADOS DE EMERGENCIA QUE LOS NO VACUNADOS. FULLY VACCINATED CHILDREN REQUIRE MUCH MORE EMERGENCY CARE THAN UNDERVACCINATED CHILDREN
A Population-Based Cohort Study of Undervaccination in 8 Managed Care Organizations Across the United States JAMA Pediatrics, January 2013, Jason M. Glanz, PhD; Sophia R. Newcomer, MPH; Komal J. Narwaney, MD, PhD; Simon J. Hambidge, MD, PhD; Matthew F. Daley, MD; Nicole M. Wagner, MPH
Summary: "Children who were undervaccinated because of pa- rental choice had lower rates of outpatient visits, lower rates of ED [emergency room] encounters.. undervaccinated children had lower outpatient visit rates compared with children who were age-appropriately vaccinated."
13. INVESTIGADORES ISRAELÍES E ITALIANOS DEMUESTRAN QUE LA EXPOSICIÓN AL ALUMINIO EN LAS VACUNAS PUEDE ACARREAR DISFUNCIÓN DEL CEREBRO Y AUTOINMUNIDAD. ISRAELI AND ITALIAN RESEARCHERS DEMONSTRATE THAT EXPOSURE TO ALUMINUM IN VACCINES CAN LEAD TO AUTOIMMUNE AND BRAIN DYSFUNCTION
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects Journal of Autoimmunity, October 2013, Carlo Perricone, Serena Colafrancesco, Roei D. Mazor, Alessandra Soriano, Yehuda Shoenfeld
Summary: "The data herein illustrate the critical role of environmental factors in the induction of autoimmunity. Indeed, it is the interplay of genetic susceptibility and environment that is the major player for the initiation of breach of tolerance. Several neurologic demyelinating diseases have been reported following vaccination, the main being Guillaine Barre? syndrome (GBS). Another demyelinating disease associated with vaccines is the acute disseminated encephalomyelitis (ADEM). This is an inflammatory disease of the central nervous system frequently occurring post-vaccination. Rabies, diphtheria tetanus polio, smallpox, measles, mumps, rubella, Japanese B encephalitis, pertussis, influenza, hepatitis B, and the Hog vaccines have been called to be involved."
14. INVESTIGADORES CANADIENSES: EL ALUMINIO EN LAS VACUNAS PUEDE CAUSAR AUTOINMUNIDAD Y DAÑO NEUROLÓGICO. CANADIAN RESEARCHERS: ALUMINUM IN VACCINES CAN CAUSE BOTH AUTOIMMUNITY AND NEUROLOGICAL DAMAGE
Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity Immunol Res, 2013, Chris Shaw, L. Tomljenovic
Summary: "In young children, a highly significant correlation exists between the number of pediatric aluminum-adjuvanted vaccines administered and the rate of autism spectrum disorders. Many of the features of aluminum- induced neurotoxicity may arise, in part, from autoimmune reactions, as part of the ASIA syndrome. Aluminum is added to vaccines to help the vaccine work more effectively, but unlike dietary aluminum which will usually clear rapidly from the body, aluminum used in vaccines and injected is designed to provide a long-lasting cellular exposure. Thus, the problem with vaccine- derived aluminum is really twofold: It drives the immune response even in the absence of a viral or bacterial threat and it can make its way into the central nervous system. It is not really a matter of much debate that aluminum in various forms can be neurotoxic."
15. CIENTÍFICOS DE MÉXICO E ISRAEL EXPLICAN QUE LOS ADYUVANTES (ALUMINIO) USADO EN LAS VACUNAS PUEDEN INDUCIR AUTOINMUNIDAD. SCIENTISTS FROM MEXICO AND ISRAEL EXPLAIN ADJUVANTS (ALUMINUM) USED IN VACCINES CAN INDUCE AUTOIMMUNITY
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum Expert Rev. Clin. Immunol. 2013 Olga Vera-Lastra, Gabriela Medina, Maria Del-Pilar Cruz Dominguez, Luis J Jara
Summary: "The activation of the immune system by adjuvants, a desirable effect, could trigger manifestations of autoimmunity or autoimmune disease. Recently, a new syndrome was introduced, autoimmune/inflammatory syndrome induced by adjuvants (ASIA), that includes postvaccination phenomena, macrophagic myofasciitis, Gulf War syndrome and siliconosis. Various adjuvants used in vaccines enhance a specific immune response against antigens and may produce autoimmunity and AID both in experimental models and humans. The clinical and laboratory data support an association between adjuvants and autoimmune diseases."
16. NIÑOS QUE RECIBIERON VACUNAS CONTENIENDO MERCURIO TIENEN MÁS ALTAS TASAS DE AUTISMO QUE LOS NIÑOS QUE RECIBIERON VACUNAS SIN MERCURIO. INFANTS RECEIVING MERCURY-CONTAINING VACCINES HAD MUCH HIGHER RATES OF AUTISM THAN INFANTS RECEIVING VACCINES WITHOUT MERCURY
A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States Translational Neurodegeneration, David A. Geier, Brian S. Hooker, Janet K. Kern, Paul G. King, Lisa K. Sykes, Mark R. Geier
Summary: "The present study provides new epidemiological evidence supporting an association between increasing organic-Hg [mercury] exposure from Thimerosal-containing childhood vaccines and the subsequent risk of ASD [autism] diagnosis."
17. CIENTÍFICOS BRITÁNICOS ADVIERTEN SOBRE LA TOXICIDAD DEL ALUMINIO Y CUESTIONAN LA FALTA DE INVESTIGACIÓN SOBRE EL ALUMINIO USADO EN VACUNAS. BRITISH SCIENTISTS SOUNDS THE ALARM ON ALUMINUM TOXICITY AND QUESTIONS LACK OF RESEARCH ON ALUMINUM USED IN VACCINES
Human exposure to aluminium Environmental Science Processes & Impacts, 2013, Christopher Exley
Summary: "The immunopotency of aluminium has been known for at least 100 years and still today forms the basis for the use of aluminium salts as adjuvants in vaccinations and allergy therapies. What is then surprising is the uncertainty regarding their mechanism of action and burgeoning evidence of their toxicity in potentially susceptible individuals."
18. INVESTIGADORES ISRAELÍES, ITALIANOS Y CANADIENSES, VINCULAN LA VACUNA HPV A LA FALLA OVÁRICA PRIMARIA. ISRAELI, ITALIAN, AND CANADIAN RESEARCHERS TIE HPV VACCINE TO PRIMARY OVARIAN FAILURE
Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants American Journal of Reproductive Immunology, 2013, Selena Colafrancesco, Carlo Perricone, Lucija Tomljenovic, Yehuda Shoenfeld
Summary: "We documented here the evidence of the potential of the HPV vaccine to trigger a life-disabling autoimmune condition. The increasing number of similar reports of post HPV vaccine-linked autoimmunity and the uncertainty of long-term clinical benefits of HPV vaccination are a matter of public health that warrants further rigorous inquiry."
19. NIÑOS QUE RECIBIERON MÁS VACUNAS TIENEN MUCHA MÁS ALTA TASA DE HOSPITALIZACIÓN Y DE MUERTE QUE NIÑOS QUE RECIBIERON MENOS VACUNAS. INFANTS WHO RECEIVED MORE VACCINES HAD MUCH HIGHER HOSPITALIZATION AND DEATH RATES THAN INFANTS WHO RECEIVED FEWER VACCINES
Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010 Human and Experimental Toxicology, 2012, GS Goldman, NZ Miller
Summary: "The hospitalization rate increased linearly from 11.0% (107 of 969) for 2 doses to 23.5% (661 of 2817) for 8 doses and decreased linearly from 20.1% (154 of 765) for children aged < 0.1 year to 10.7% (86 of 801) for children aged 0.9 year. Our findings show a positive correlation between the number of vaccine doses administered and the percentage of hospitalizations and deaths. Since vaccines are given to millions of infants annually, it is imperative that health authorities have scientific data from synergistic toxicity studies on all combinations of vaccines that infants might receive. Finding ways to increase vaccine safety should be the highest priority."
20. CIENTÍFICOS ISRAELÍES EXPLICAN EL PAPEL QUE LOS ADYUVANTES DE VACUNAS (ALUMINIO) JUEGAN EN LAS ENFERMEDADES AUTOINMUNES. ISRAELI SCIENTISTS EXPLAIN ROLE VACCINE ADJUVANTS (ALUMINUM) ARE PLAYING IN AUTOIMMUNE DISEASES
The spectrum of ASIA: 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' Lupus, 2012, N Agmon-Levin, GRV Hughes, Y Shoenfeld
Summary: "It seems that the role of adjuvants [aluminum in vaccines] in the pathogenesis of immune-mediated diseases can no longer be ignored, and the medical community must look towards producing safer adjuvants. Another cornerstone of ASIA is the complex interaction between autoimmunity and adjuvanted vaccines. On the one hand vaccines are beneficial for the vast majority of subjects including those who suffer from autoimmune-rheumatic diseases as delineated in this issue by van Assen and Bijl.16 On the other hand in a small minority of individuals vaccine can trigger the appearance of autoan- tibodies as documented by Vista et al.17 and Perdan-Pirkmajer et al.18 Moreover, a link between immunization and defined autoimmune diseases has been reported elsewhere and herein."
21. CIENTÍFICOS POLACOS PROPONEN UN NUEVO CALENDARIO DE VACUNAS, EXPRESAN PREOCUPACIÓN POR LAS ALTAS TASAS DE EFECTOS ADVERSOS OCASIONADOS POR LAS VACUNAS. POLISH SCIENTISTS PROPOSE NEW VACCINE SCHEDULE, EXPRESS CONCERN AT HIGH RATE OF VACCINE ADVERSE EVENTS
Neurologic adverse events following vaccination Prog Health Sci, 2012, Sienkiewicz D., Ku?ak W., Okurowska-Zawada B., Paszko-Patej G.
Summary: "Thus, it is not reasonable to assume that manipulation of the immune system through an increasing number of vaccinations during critical periods of brain development will not result in adverse neurodevelopmental outcomes. European countries have different models of vaccination that have been modified in recent decades. In Scandinavian countries, which have the lowest infant mortality, vaccinations are voluntary and infants receive their first vaccination at 3 months of age. In the first year of life, they receive 9 recommended vaccinations, and at 18 months - MMR. The acellular pertussis vaccine (DTaP) is used, as well as IPV. BCG and Hepatitis B vaccines are administered to children from high risk groups. Similar vaccination schedules exist in other European countries, where the vaccination of neonates was abandoned and a ban on the use of thimerosal in vaccines was introduced. Note also that Scandinavian countries have the lowest rates of autism compared to other developed countries in which children are vaccinated much earlier and with greater number of vaccines."
22. INVESTIGADORES CANADIENSES REVISAN LA LITERATURA SOBRE AUTOINMUNIDAD Y RIESGOS NEUROLÓGICOS DEL ADYUVANTE DE LAS VACUNAS, ALUMINIO, EXPRESAN DUDAS ACERCA DE LAS PRUEBAS DE SEGURIDAD. CANADIAN RESEARCHERS REVIEW LITERATURE ON AUTOIMMUNITY AND NEUROLOGICAL RISKS FROM VACCINE ADJUVANT ALUMINUM, EXPRESS DOUBTS REGARDING SAFETY TESTING
Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations, Lupus, 2012, L Tomljenovic, CA Shaw
Summary: “Immune challenges during early development, including those vaccine-induced, can lead to permanent detrimental alterations of the brain and immune function. Experimental evidence also shows that simultaneous administration of as little as two to three immune adjuvants can overcome genetic resistance to autoimmunity. In spite of the widespread agreement that vaccines are largely safe and serious adverse complications are extremely rare, a close scrutiny of the scientific literature does not support this view. For example, to date, the clinical trials that could adequately address vaccine safety issues have not been con- ducted (i.e., comparing health outcomes in vaccinated versus non-vaccinated children). Infants and young children should not be viewed as ‘’small adults.’’ Their unique physiology makes them much more vulnerable to noxious environ- mental insults in comparison with the adult population. In spite of this, children are routinely exposed to much higher levels of Al vaccine adjuvants than adults, even though adequate safety data on these compounds are lacking. That Al vaccine adjuvants can induce significant autoimmune conditions in humans can hardly be disputed, although still debatable is how common such side effects are. However, the existing data (or lack thereof) raise questions on whether the current vaccines aimed at pediatric populations can be accepted as having adequate safety profiles. Because infants and children represent those who may be most at risk for complications following vaccination, a more rigorous evaluation of potential vaccine-related adverse health impacts in pediatric populations than what has been provided to date is urgently needed.”
23. INVESTIGADORES DANESES ENCONTRARON QUE LOS NIÑOS TIENEN 8 VECES MÁS PROBABILIDAD DE TENER UNA CONVULSIÓN FEBRIL EL DÍA DE LA VACUNACIÓN. DANISH RESEARCHERS FOUND CHILDREN 8-TIMES MORE LIKELY TO HAVE A FEBRILE SEIZURE ON THE DAY OF VACCINATION OF DTAP-IPV-HIB VACCINE
Risk of Febrile Seizures and Epilepsy After Vaccination With Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, and Haemophilus Influenzae Type b JAMA 2012, Yuelian Sun, Jakob Christensen, Anders Hviid, Jiong Li
Summary: "DTaP-IPV-Hib vaccination was associated with an increased risk of febrile seizures on the day of the first 2 vaccinations given at 3 and 5 months."
24. INVESTIGADORES CANADIENSES INFORMAN ACERCA DE LA RELACIÓN ENTRE EL AUTISMO Y EL ALUMINIO EN LAS VACUNAS. CANADIAN RESEARCHERS REPORT VACCINE ALUMINUM AND AUTISM PREVALENCE RELATED
Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorg Biochem. Tomljenovic L, Shaw CA.
Summary: "Dysfunctional immunity and impaired brain function are core deficits in ASD. Aluminum (Al), the most commonly used vaccine adjuvant, is a demonstrated neurotoxin and a strong immune stimulator. Hence, adjuvant Al has the potential to induce neuroimmune disorders. The application of the Hill's criteria to these data indicates that the correlation between Al in vaccines and ASD may be causal. Because children represent a fraction of the population most at risk for complications following exposure to Al, a more rigorous evaluation of Al adjuvant safety seems warranted.. By satisfying eight of the Hill's criteria for establishing causality applicable to our study, we show that Al-adjuvanted vaccines may be a significant etiological factor in the rising prevalence of ASD in the Western world. We also show that children from countries with the highest ASD prevalence appear to have a much higher exposure to Al from vaccines, particularly at 2 months of age."
25. INVESTIGADORES DE HARVARD ENCUENTRAN QUE EL MERCURIO EN LAS VACUNAS IMPACTA EN EL DESARROLLO NEUROLÓGICO EN RATAS. HARVARD RESEARCHERS FIND VACCINE MERCURY IMPACTS NEURODEVELOPMENT IN RATS
Maternal Thimerosal Exposure Results in Aberrant Cerebellar Oxidative Stress, Thyroid Hormone Metabolism, and Motor Behavior in Rat Pups; Sex- and Strain-Dependent Effects Cerebellum, 2012, Z. L. Sulkowski & T. Chen & S. Midha & A. M. Zavacki & Elizabeth M. Sajdel-Sulkowska
Summary: "Our data indicate that maternal TM exposure results in a delayed auditory maturation and impaired motor learning in rat pups. Factors that may contribute to these abnormalities include increased cerebellar oxidative stress and decreased D2 activity resulting local intracerebellar T3 deficiency and altered TH-dependent gene expression. Indeed, provided here is the first evidence of altered TH-dependent gene expression following TM exposure. Our data thus demonstrate a negative neurodevelopmental impact of perinatal TM exposure, which appears to be both strain- and sex-dependent. Although, additional studies are needed, data derived from TM exposure in rats may provide clues relevant to understanding neurodevelopmental consequences of TM exposure in humans.
26. NIÑOS VARONES QUE RECIBIERON LA VACUNA DE LA HEPATITIS B ES TRES VECES MÁS PROBABLE QUE TENGAN AUTISMO. SUNY-STONY BROOK SCIENTISTS FIND BOYS RECEIVING THE HEPATITIS B VACCINE SERIES WERE THREE TIMES MORE LIKELY TO HAVE AUTISM
Hepatitis B Vaccination of Male Neonates and Autism Diagnosis, NHIS 1997-2002 Journal of Toxicology and Environmental Health, April 2010, Carolyn Gallagher and Melody Goodman
Summary: "Boys vaccinated as neonates had threefold greater odds for autism diagnosis compared to boys never vaccinated or vaccinated after the first month of life. Findings suggest that U.S. male neonates vaccinated with the hepatitis B vac- cine prior to 1999 (from vaccination record) had a threefold higher risk for parental report of autism diagnosis compared to boys not vaccinated as neonates during that same time period."
27. CIENTÍFICOS BRITÁNICOS Y SUECOS PREOCUPADOS ACERCA DE LA COMPRENSIÓN LIMITADA DEL IMPACTO EN EL CUERPO HUMANO DEL ALUMINIO EN LAS VACUNAS, ELEVA EL RIESGO DE LA RESPUESTA AUTOINMUNE. BRITISH AND SWEDISH SCIENTISTS RAISE CONCERNS ABOUT LIMITED UNDERSTANDING OF VACCINE ALUMINUM'S IMPACT ON THE HUMAN BODY, RAISE RISK OF AUTOIMMUNE RESPONSE
The immunobiology of aluminium adjuvants: how do they really work? Trends in Immunology 2010, Christopher Exley, Peter Siesjo, Hakan Eriksson
Summary: "Aluminium adjuvants potentiate the immune response, thereby ensuring the potency and efficacy of typically sparingly available antigen. Their concomitant critical importance in mass vaccination programmes may have prompted recent intense interest in understanding how they work and their safety. Progress in these areas is stymied, however, by a lack of accessible knowledge pertaining to the bioinorganic chemistry of aluminium adjuvants, and, consequently, the inappropriate application and interpretation of experimental models of their mode of action.. In relation to this possible 'indirect adjuvanticity' there are burgeoning examples in the scientific literature of aluminium salts inducing sen- sitization to substances that might not normally be considered as antigens. For example, such effects may contribute towards allergies to foods"
28. MONOS BEBES A LOS QUE SE LES DIÓ LAS DOSIS DEL CALENDARIO DE VACUNACIÓN DE ESTADOS UNIDOS TIENEN ANORMALIDADES EN EL CEREBRO EN LA REGIÓN RESPONSABLE DEL DESARROLLO SOCIAL Y EMOCIONAL. BABY MONKEYS GIVEN U.S. VACCINE SCHEDULE HAD BRAIN ABNORMALITIES IN REGION RESPONSIBLE FOR SOCIAL AND EMOTIONAL DEVELOPMENT
Influence of pediatric vaccines on amygdala growth and opioid ligand binding in rhesus macaque infants: A pilot study Acta Neurobiol Exp, 2010, Laura Hewitson, Brian J. Lopresti, Carol Stott
Summary: "The data suggest that vaccine exposure may be asso- ciated with significant disturbances in central opioidergic pathways in this model... Volumetric analyses identified significantly greater total brain volume in exposed compared with unexposed animals at both measured time points. These results raise the possibility that multiple vaccine exposures during the previous 3-4 months may have had a significant impact on brain growth and development."
29. CIENTÍFICOS PREOCUPADOS ACERCA DE LA NEGACIÓN DE LAS TOXINAS AMBIENTALES LIGADAS CON EL AUTISMO. SCIENTISTS RAISE CONCERNS ABOUT DENIAL OF ENVIRONMENTAL TOXIN LINK TO AUTISM, REVIEW LIETRATURE
Sorting out the spinning of autism: heavy metals and the question of incidence Acta Neurobiol, 2010 Mary Catherine DeSoto and Robert T. Hitlan
Summary: "In this paper, we argue that increasingly over the past decade, positions that deny a link to environmental toxins and autism are based on relatively weak science and are disregarding the bulk of scientific literature. The question about toxic exposure and autism is open, with the weight of evidence favoring a connection that is not well understood. Although it is not possible to say with certainty, it seems likely that the connection would be mediated by genetic susceptibility and ability to detoxify. That is, some people have genotypes that confer higher susceptibility to toxic exposures. If so, then 50 years ago few people would have had enough toxic exposure to have the neurological changes that result in autism."
30. INVESTIGADORES ADVIERTEN DE LA CONSIDERABLE DIFERENCIA EN LAS REACCIONES INDIVIDUALES A LAS VACUNAS, ACENTÚAN LA NECESIDAD DE EVITAR EL INCREMENTO DE EFECTOS SECUNDARIOS DE LAS VACUNAS. RESEARCHERS WARN OF SIZABLE DIFFERENCE IN INDIVIDUAL REACTION TO VACCINES, STRESS NEED TO AVOID INCREASING SIDE EFFECTS OF VACCINES Interindividual variations in the efficacy and toxicity of vaccines
Toxicology 2010, Thomas C, Moridani M
Summary: "A number of currently available vaccines have shown significant differences in the magnitude of immune responses and toxicity in individuals undergoing vaccination. A number of factors may be involved in the variations in immune responses, which include age, gender, race, amount and quality of the antigen, the dose administered and to some extent the route of administration, and genetics of immune system. Hence, it becomes imperative that researchers have tools such as genomics and proteomics at their disposal to predict which set of population is more likely to be non-responsive or develop toxicity to vaccines.. With the increasing number of side effects associated with a number of vaccines reported over the years, it has become imperative to develop new technologies that can effectively assist in the development and evaluation of vaccines for efficacy and toxicity."
31. ALUMINIO DE LAS VACUNAS INYECTADO EN RATAS CREA SIGNIFICATIVO DÉFICIT MOTOR Y DEGENERACIÓN NEUROLÓGICA MOTORA. VACCINE ALUMINUM INJECTED INTO MICE CREATED SIGNIFICANT MOTOR DEFICITS AND MOTOR NEURON DEGENERATION
Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration Journal of Inorg Biochem, February 2010, Christopher A. Shaw, Michael S. Petrik
Summary: "Aluminum-treated mice showed significantly increased apoptosis of motor neurons and increases in reactive astrocytes and microglial proliferation within the spinal cord and cortex. Morin stain detected the presence of aluminum in the cytoplasm of motor neurons with some neurons also testing positive for the presence of hyper-phosphorylated tau protein, a pathological hallmark of various neurological diseases, including Alzheimer's disease and frontotemporal dementia. A second series of experiments was conducted on mice injected with six doses of aluminum hydroxide. Behavioural analyses in these mice revealed significant impairments in a number of motor functions as well as diminished spatial memory capacity. The demonstrated neurotoxicity of aluminum hydroxide and its relative ubiquity as an adjuvant suggest that greater scrutiny by the scientific community is warranted. Overall, the results reported here mirror previous work that has clearly demonstrated that aluminum, in both oral and injected forms, can be neurotoxic."
32. MONOS RECIÉN NACIDOS A LOS QUE SE LES DIÓ LA VACUNA CONTRA LA HEPATITIS B CONTENIENDO MERCURIO, TUVIERON RETRASO SIGNIFICATIVO EN REFLEJOS NEONATALES Y DESARROLLO NEUROLÓGICO. NEWBORN MONKEYS GIVEN A MERCURY-CONTAINING HEPATITIS B VACCINE HAD SIGNIFICANT DELAYS IN NEONATAL REFLEXES AND NEUROLOGICAL DEVELOPMENT
Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing Hepatitis B vaccine: Influence of gestational age and birth weight Neurotoxicology, Sep 2009 Laura Hewitson et. al.
Summary: "In summary, this study provides preliminary evidence of abnormal early neurodevelopmental responses in male infant rhesus macaques receiving a single dose of Th-containing HB vaccine at birth and indicates that further investigation is merited."
33. CIENTÍFICOS FRANCESES REPORTAN QUE EL ALUMINIO DE LAS VACUNAS CAUSA DISFUNCIÓN COGNITIVA CRÓNICA. FRENCH SCIENTISTS REPORT ALUMINUM FROM VACCINES CAUSES CHRONIC COGNITIVE DYSFUNCTION
Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction Journal of Inorganic Biochemistry, 2009, Couette M1, Boisse MF, Maison P, Brugieres P, Cesaro P, Chevalier X, Gherardi RK, Bachoud-Levi AC, Authier FJ.
Summary: "In conclusion, long-term persistence of vaccine-derived aluminum hydroxide within the body assessed by MMF is associated with cognitive dysfunction, not solely due to chronic pain, fatigue and depression. In conclusion, this work is the first firm demonstration that cognitive dysfunction is a central feature in MMF, this dysfunction being much more frequent and severe than suspected by routine neurological evaluation. Instead of being a non-specific bystander effect of pain, fatigue or depression, MACD seems to reflect an underlying organic, inflammatory or toxic, brain involvement."
34. INVESTIGADOR SUECO ENCONTRÓ QUE LOS NIÑOS QUE TUVIERON SARAMPIÓN NATURALMENTE, TUVIERON MUCHO MÁS BAJAS TASAS DE ALERGIA QUE LOS NIÑOS VACUNADOS CONTRA SARAMIÓN. SWEDISH RESEARCHERS FOUND THAT CHILDREN WHO HAD NATURAL MEASLES INFECTION HAD MUCH LOWER RATES OF ALLERGY THAN CHILDREN VACCINATED AGAINST MEASLES
Allergic Disease and Atopic Sensitization in Children in Relation to Measles Vaccination and Measles Infection Pediatrics 2009 Rosenlund H1, Bergstrom A, Alm JS, Swartz J, Scheynius A, van Hage M, Johansen K, Brunekreef B, von Mutius E, Ege MJ, Riedler J, Braun-Fahrlander C, Waser M, Pershagen G; PARSIFAL Study Group.
Summary: "However, in these analyses, measles infection [natural measles] was inversely associated with any allergic symptom or physician's diagnosis of allergy."
35. NIÑOS VARONES QUE RECIBIERON LA VACUNA CONTRA LA HEPATITIS B ES NUEVE VECES MÁS PROBABLE QUE NECESITEN EDUCACIÓN ESPECIAL Y SEAN DISCAPACITADOS EN SU DESARROLLO. BOYS RECEIVING THE HEPATITIS B VACCINE SERIES WERE NINE TIMES FOR LIKELY TO NEED SPECIAL EDUCATION AND BE DEVELOPMENTALLY DISABLED
Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years Toxicological and Environmental Chemistry, September 2008,?Carolyn Gallagher and Melody Goodman
Summary: "This study investigated the association between vaccination with the Hepatitis B triple series vaccine. The odds of receiving Special Education were approximately nine times as great for vaccinated boys (n 1/4 46) as for unvaccinated boys (n 1/4 7), after adjustment for confounders. This study found statistically significant evidence to suggest that boys in United States who were vaccinated with the triple series Hepatitis B vaccine, were more susceptible to developmental disability than were unvaccinated boys."
36. NIÑOS QUE DEMORARON LA COLOCACIÓN DE LA VACUNA CONTRA LA DIFTERIA, EL TÉTANOS Y LA TOS CONVULSA, TUVIERON TASAS MÁS BAJAS DE ASMA. CHILDREN WHO DELAYED THE TIMING OF THE DPT VACCINE HAD LOWER RATES OF ASTHMA
Delay in diphtheria, pertussis, tetanus vaccination is associated with a reduced risk of childhood asthma? Journal of Allergy and Clinical Immunology, 2008, Kara L. McDonald, MS, Shamima I. Huq, BS
Summary: "Early childhood immunizations have been viewed as promoters of asthma development by stimulating a T(H)2-type immune response or decreasing microbial pressure, which shifts the balance between T(H)1 and T(H)2 immunity. Among 11, 531 children who received at least 4 doses of DPT, the risk of asthma was reduced to (1/2) in children whose first dose of DPT was delayed by more than 2 months."
37. TASAS MUCHO MÁS ALTAS DE DISCAPACIDADES NEUROLÓGICAS DE VACUNAS CONTENIENDO MERCURIO. A CDC-SPONSORED DATABASE SHOWED MUCH HIGHER RATES OF NEURODEVELOPMENTAL DISABILITIES FROM MERCURY-CONTAINING VACCINES
Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink Journal of the Neurological Sciences, March 2008, Heather A. Young, David A. Geier, Mark R. Geier
Summary: "Consistent significantly increased rate ratios were observed for autism, autism spectrum disorders, tics, attention deficit disorder, and emotional disturbances with Hg exposure from TCVs. By contrast, none of the control outcomes had significantly increased rate ratios with Hg exposure from TCVs."
38. CIENTÍFICOS AUSTRALIANOS DESCRIBEN EL ROL DE LAS VACUNAS EN DISPARAR ENCEFALOMIELITIS AGUDA. AUSTRALIAN SCIENTISTS DESCRIBE THE ROLE OF VACCINES IN TRIGGERING ACUTE DISSEMINATED ENCEPHALOMYELITIS ("ADEM")
Post-vaccination encephalomyelitis: Literature review and illustrative case Journal of Clinical Neuroscience, 2008, Huynh W1, Cordato DJ, Kehdi E, Masters LT, Dedousis C.
Summary: "Post-infectious and post-immunisation encephalomyelitis make up about three-quarters of cases, where the timing of a febrile event is associated with the onset of neurological disease..Post-vaccination Acute disseminated encephalomyelitis has been associated with several vaccines such as rabies, diphtheria-tetanus-polio, smallpox, measles, mumps, rubella, Japanese B encephalitis, pertussis, influenza, hepatitis B, and the Hog vaccine. We review ADEM with particular emphasis on vaccination as the precipitating factor."
39. EL MERCURIO USADO COMO PRESERVATIVO EN VACUNAS ES MUCHO MÁS TÓXICO QUE EL MERCURIO ENCONTRADO EN PECES. THE MERCURY USED AS A VACCINE PRESERVATIVE IS FAR MORE NEUROTOXIC THAN THE MERCURY FOUND IN FISH
Comparison of Blood and Brain Mercury Levels in Infant Monkeys Exposed to Methylmercury or Vaccines Containing Thimerosal Environmental Health Perspectives, August 2005, Thomas M. Burbacher, Danny D. Shen, Noelle Liberato, Kimberly S. Grant, Elsa Cernichiari, and Thomas Clarkson
Summary: The mercury used in vaccines (and still in the flu vaccine given to pregnant women) is far more toxic than the mercury found in fish, because it stays in the brain at much higher levels. "Data from the present study support the prediction that, although little accumulation of Hg in the blood occurs over time with repeated vaccinations, accumulation of Hg in the brain of infants will occur. Thus, conclusion regarding the safety of thimerosal drawn from blood Hg clearance data in human infants receiving vaccines may not be valid, given the significantly slower half-life of Hg in the brain as observed in the infant macaques. There was a much higher proportion of inorganic Hg in the brain of thimerosal monkeys than in the brains of MeHg monkeys (up to 71% vs. 10%). Absolute inorganic Hg concentrations in the brains of the thimerosal-exposed monkeys were approximately twice that of the MeHg monkeys."
40. EL MERCURIO EN LAS VACUNAS DISMINUYE UN ANTIOXIDANTE VITAL, EL GLUTATION VACCINE MERCURY DEPLETES A VITAL ANTIOXIDANT, GLUTATHIONE
Thimerosal Neurotoxicity is Associated with Glutathione Depletion: Protection with Glutathione Precursors Neurotoxicology, Jan 2005, S. Jill James, PhD
Summary: "Thimerosal is an antiseptic containing 49.5% ethyl mercury that has been used for years as a preservative in many infant vaccines and in flu vaccines. Environmental methyl mercury has been shown to be highly neurotoxic, especially to the developing brain. Because mercury has a high affinity for thiol (sulfhydryl (-SH)) groups, the thiol-containing antioxidant, glutathione (GSH), provides the major intracellular defense against mercury-induced neurotoxicity. Cultured neuroblastoma cells were found to have lower levels of GSH and increased sensitivity to thimerosal toxicity compared to glioblastoma cells that have higher basal levels of intracellular GSH. Thimerosal-induced cytotoxicity was associated with depletion of intracellular GSH in both cell lines. Although Thimerosal has been recently removed from most children's vaccines, it is still present in flu vaccines given to pregnant women, the elderly, and to children in developing countries."
41. CIENTÍFICOS IDENTIFICAN EL PAPEL DEL MERCURIO CONTENIDO EN LAS VACUNAS EN BLOQUEAR REDES NEURONALES CRUCIALES EN EL DESARROLLO NEUROLÓGICO. SCIENTISTS IDENTIFY VACCINE MERCURY'S ROLE IN BLOCKING CRUCIAL NEURODEVELOPMENTAL PATHWAYS
Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal Molecular Psychiatry, 2004, M Waly, H Oltaneu, R Banerjee, S-W Choi, JB Mason, BS Parker, S Sukumar, S Shim, A Sharma
Summary: "The ethylmercury-containing preservative thimerosal inhibited both IGF-1- and dopamine-stimulated methylation with an IC50 of 1nM and eliminated MS activity. Our findings outline a novel growth factor signaling pathway that regulates MS activity and thereby modulates methylation reactions, including DNA methylation. The potent inhibition of this pathway by ethanol, lead, mercury, aluminum and thimerosal suggest that it may be an important target of neurodevelopmental toxins."
42. CIENTÍFICOS DEL ESTADO DE UTAH ENCUENTRAN REACCIÓN AUTOINMUNE A LA MMR EN NIÑOS CON AUTISMO. UTAH STATE SCIENTISTS FIND AUTOIMMUNE REACTION TO MMR IN CHILDREN WITH AUTISM, INCLUDING AUTOIMMUNITY TO MYELIN BASIC PROTEIN, A BRAIN BUILDING-BLOCK
Abnormal Measles-Mumps-Rubella Antibodies and CNS Autoimmunity in Children with Autism J Biomed Sci, 2002, Vijendra K. Singh Sheren X. Lin Elizabeth Newell Courtney Nelson
Summary: "And, as described herein, autistic children showed a serological correlation between MMR and brain autoimmunity, i.e., over 90% of MMR antibody-positive autistic sera also had autoantibodies to brain MBP. This is quite an intriguing observation in favor of a connection between atypical measles infection and autism; an atypical infection usually refers to infection that occurs in the absence of a rash. An atypical measles infection in the absence of a rash and unusual neurological symptoms was recently described to suggest the existence of a variant MV in children and adults . In light of these new findings, we suggest that a considerable proportion of autistic cases may result from an atypical measles infection that does not produce a rash but causes neurological symptoms in some children. The source of this virus could be a variant MV or it could be the MMR vaccine."
43. CIENTÍFICOS FRANCESES VINCULAN EL ALUMINIO EN LAS VACUNAS A LA MYOFASCIITIS MACROFÁGICA. FRENCH SCIENTISTS TIE ALUMINUM ADJUVANT IN VACCINE TO MACROPHAGIC MYOFASCIITIS
Macrophagic myofasciitis lesions assess long-term persistence of vaccine derived aluminum hydroxide in muscle Brain, 2001 R.K. Gherardi, M. Coquet, P. Cherin, L. Belec, P. Moretto, P.A. Dreyfus
Summary: "Macrophagic myofasciitis (MMF) is an emerging condition of unknown cause, detected in patients with diffuse arthromyalgias and fatigue, and characterized by muscle infiltration by granular periodic acid-Schiff's reagent-positive macrophages and lymphocytes. Intracytoplasmic inclusions have been observed in macrophages of some patients. To assess their significance, electron microscopy was performed in 40 consecutive cases and chemical analysis was done by microanalysis and atomic absorption spectrometry. Inclusions were constantly detected and corresponded to aluminium hydroxide, an immunostimulatory compound frequently used as a vaccine adjuvant."
44. CIENTÍFICOS JAPONESES ENCUENTRAN CEPA DE LA VACUNA DEL SARAMPIÓN EN EL INTESTINO DE NIÑOS CON AUTISMO. JAPANESE SCIENTISTS FIND VACCINE-STRAIN OF MEASLES IN THE GUTS OF CHILDREN WITH AUTISM
Detection and Sequencing of Measles Virus from Peripheral Mononuclear Cells from Patients with Inflammatory Bowel Disease and Autism Digestive Diseases and Sciences, 2000, Hisashi Kawashima, Takayuki Mori, Yasuyo Kashiwagi, Kouji Takekuma
Summary: "Additionally, a new syndrome has been reported in children with autism who exhibited developmental regression and gastrointestinal symptoms (autistic enterocolitis), in some cases soon after MMR vaccine. The sequences obtained from the patients with ulcerative colitis and children with autism were consistent with being vaccine strains. The results were concordant with the exposure history of the patients. Persistence of measles virus was confirmed in PBMC in some patients with chronic intestinal inflammation."
45. CIENTÍFICOS DE LA CDC ADMITEN QUE EL 90% DE LA MORTALIDAD EN LAS ENFERMEDADES INFECCIOSAS DISMINUYÓ ANTES QUE LAS VACUNAS ESTUVIERAN DISPONIBLES. CDC SCIENTISTS ADMIT THAT 90% OF INFECTIOUS DISEASE MORTALITY DECREASE IN THE UNITED STATES HAPPENED BEFORE VACCINES WERE AVAILABLE
Annual Summary of Vital Statistics: Trends in the Health of Americans During the 20th Century Pediatrics, December 2000, Bernard Guyer, MD, Mary Anne Freeman, MA, Donna M. Strobino, PhD, Edward J. Sondik, PhD
Summary: "Thus vaccination does not account for the impressive declines in mortality seen in the first half of the century...nearly 90% of the decline in infectious disease mortality among US children occurred before 1940, when few antibiotics or vaccine were available."
46. LAS VACUNAS CON MERCURIO ELEVÓ LOS NIVELES DE MERCURIO EN EL CUERPO DE LOS NIÑOS SIGNIFICATIVAMENTE.VACCINES WITH MERCURY SIGNIFICANTLY RAISED THE BODY LEVELS OF MERCURY IN INFANTS
Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants The Journal of Pediatrics, May 2000, Gregory V. Stajich, PharmD, Gaylord P. Lopez, PharmD, ABAT, Sokei W. Harry, MBBS, MPH, William R. Sexson, MD
Summary: "Thimerosal, a derivative of mercury, is used as a preservative in hepatitis B vaccines. We measured total mercury levels before and after the administration of this vaccine in 15 preterm and 5 term infants. Comparison of pre- and post-vaccination mercury levels showed a significant increase in both preterm and term infants after vaccination. Additionally, post-vaccination mercury levels were significantly higher in preterm infants as compared with term infants. Because mercury is known to be a potential neurotoxin to infants, further study of its pharmacodynamics is warranted."
47. INVESTIGADORES DE UCLA ENCUENTRAN QUE LA VACUNA DE LA DIFTERIA, EL TÉTANOS Y LA TOS CONVULSA CAUSA ASMA. UCLA RESEARCHERS FIND THE DTP VACCINE IS CAUSING ASTHMA
Effects of Diphtheria-Tetanus-Pertussis or Tetanus Vaccination on Allergies and Allergy-Related Respiratory Symptoms Among Children and Adolescents in the United States Journal of Manipulative and Physiological Therapeutics, 2000, Eric Hurwitz and Hal Morgenstern
Summary: "Asthma and other allergic hypersensitivity reactions and related symptoms may be caused, in part, by the delayed effects of DTP or tetanus vaccination. Because the proportion of US children who have received at least 1 dose of DTP vaccine approaches 100%, the number of allergies and allergy-related conditions attributable to DTP or tetanus vaccination in the United States may be very high. For example, assuming that the estimated vaccination effect is unbiased, 50% of diagnosed asthma cases (2.93 million) in US children and adolescents would be prevented if the DTP or tetanus vaccination was not administered."
48. NIÑOS QUE RECIBIERON VACUNAS CONTENIENDO MERCURIO DESARROLLARON DESÓRDENES EN EL HABLA, EN EL SUEÑO Y AUTISMO DE ACUERDO CON CIENTÍFICOS DE LA CDC. INFANTS RECEIVING MERCURY-CONTAINING VACCINES DEVELOPED SPEECH DISORDERS, SLEEP DISORDERS, AND AUTISM, ACCORDING TO CDC SCIENTISTS
Increased risk of developmental neurologic impairment after high exposure to thimerosal-containing vaccine in first month of life Proceedings of the Epidemic Intelligence Service Annual Conference, April 2000, Verstraeten T, Davis RL, Gu D, DeStefano F.
Summary: "This analysis suggests that high exposure to ethylmercury from thimerosal-containing vaccines in the first month of life increases the risk of subsequent development of neurologic development impairment."
49. LAS TASAS DE ENFERMEDADES INFECCIOSAS DECLINARON PRECIPITADAMENTE EN LOS ESTADOS UNIDOS EN EL SIGLO 20 ANTES DE LA IMPLEMENTACIÓN DEL PROGRAMA NACIONAL DE VACUNACIÓN. INFECTIOUS DISEASE RATES DECLINED PRECIPITOUSLY IN THE UNITED STATES IN THE 20TH CENTURY BEFORE THE IMPLEMENTATION OF A NATIONAL VACCINE PROGRAM
Trends in Infectious Disease Mortality in the United States During the 20th Century JAMA, January 6, 1999, Gregory L. Armstrong, MD, Laura A. Conn, MPH, Robert W. Pinner, MD
Summary: "During the first 8 decades of the 20th century, the infectious disease mortality rate in the United States declined substantially...Improvements in living conditions, sanitation, and medical care probably accounted for this trend."
50. CIENTÍFICOS DEL CDC ENCUENTRAN QUE LOS CHICOS VACUNADOS CON LA MMR CONTAGIAN EL SARAMPIÓN POR, AL MENOS, DOS SEMANAS DESPUÉS DE SER VACUNADOS. CDC SCIENTISTS FIND CHILDREN GIVEN THE MMR VACCINE SHED THE MEASLES VIRUS FOR AT LEAST 2 WEEKS AFTER GETTING THE VACCINE, MAKING THEM VECTORS TO SPREAD MEASLES
Detection of Measles Virus RNA in Urine Specimens from Vaccine Recipients Journal of Clinical Microbiology, Sept 1995, Paul A. Rota, Ali S. Khan, Edison Durigon, Thomas Yuron, and William Bellini
Summary: "For the study, daily urine samples were obtained from either 15- month-old children or young adults following measles immunization. Overall, measles virus RNA was detected in 10 of 12 children during the 2-week sampling period. In some cases, measles virus RNA was detected as early as 1 day or as late as 14 days after vaccination. Measles virus RNA was also detected in the urine samples from all four of the young adults between 1 and 13 days after vaccination. This assay will enable continued studies of the shedding and transmission of measles virus and, it is hoped, will provide a rapid means to identify measles infection, especially in mild or asymptomatic cases."
. Desvaneciendo ilusiones. Suzanne Hamphries, MD
. Vaccine Illusion. Tetyana Obukhanych, Phd
. The truth about vaccines.
. Vaccines Revealed.
. Vaxxed. Del encubrimiento a la catástrofe.
. Trace amounts.
. The age of autism.
. Shots in the Dark.
. https://www.facebook.com/ChildrensHealthDefense/ - Robert F. Kennedy Jr